OpenVSafe by OpenVAERS
Search V-safe

N54-13331-08034

3 vaccinations 4 coded responses 10 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
460 / IN
Registered
2021-04-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-19
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-13
    Dose 2 — Pfizer-BioNTech
  3. 2021-04-15
    Registered in v-safe
  4. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest discomfort — Feeling: Fair · Chills, Muscle or body aches, Fatigue or tiredness
    Free text: Chest tightness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-04-20
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-04-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-07-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-10-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-12-23
    Dose 3 — Pfizer-BioNTech
  12. 2022-04-13
    Survey response — 12 months, dose 2
    MedDRA: Anxiety, Depression, Gastrointestinal disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Stomach issues, possible gallbladder needs to be removed, anxiety and depression.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-04-13
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  14. 2022-04-14
  15. 2022-06-25
    Survey response — 6 months, dose 3
    MedDRA: Nausea, Vomiting — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nausea, vomiting since November.
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-12-23
    Survey response — 12 months, dose 3
    MedDRA: Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Nausea of unknown etiology for 14 months.
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-12-23
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  18. 2022-12-27
  19. 2022-12-27

Vaccinations

DoseDateManufacturerCo-administered
12021-03-19Pfizer-BioNTech
22021-04-13Pfizer-BioNTech
32021-12-23Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-16

Systemic reaction (other): Chest tightness

Release 11 — 12 months, dose 2

2022-04-13

Symptoms: Stomach issues, possible gallbladder needs to be removed, anxiety and depression.

Release 12 — 6 months, dose 3

2022-06-25

Symptoms: Nausea, vomiting since November.

Release 12 — 12 months, dose 3

2022-12-23

Symptoms: Nausea of unknown etiology for 14 months.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety · · ✓
SDDepression · · ✓
SDGastrointestinal disorder · · ✓
SDNausea · · ✓
SDVomiting · · ✓
SROChest discomfort ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release